Remote Assessment of Disease and Relapse – Central Nervous System (RADAR-CNS) is a new collaborative research programme that will explore the potential of wearable devices to help prevent and treat depression and epilepsy.
RADAR-CNS is jointly led by King’s College London and Janssen Pharmaceutica NV, funded by the Innovative Medicines Initiative (a Public Private Partnership established between the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the European Union) and includes 22 organisations from across Europe and the US. It brings together experts from diverse fields including clinical research, engineering, computer science, information technology, data analytics and health services.
To find out more click here https://www.radar-cns.org/
To link to questionnaire click link here https://www.radar-cns.org/newsroom/radar-cns-team-seeks-views-health-professionals-0